Skip to Main Content
Yale School of Medicine
YSM Home

INFORMATION FOR

Stuart Seropian, MD

Professor of Internal Medicine (Hematology)
DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Additional Titles

Acting Director, Stem Cell Transplantation

Chairman, Car-T Cell Joint Steering Committee

Director, Unrelated Donor Transplant Program, Stem Cell Transplantation

Co-Director, Immune Effector Cell Therapy

Co-Director, Adult CAR T-Cell Therapy Program

Contact Info

stuart.seropian@yale.edu

Yale Cancer Center

PO Box 208028, 333 Cedar Street, TMP 3

New Haven, CT 06520-8028

United States

About

Titles

Professor of Internal Medicine (Hematology)

Acting Director, Stem Cell Transplantation; Chairman, Car-T Cell Joint Steering Committee; Director, Unrelated Donor Transplant Program, Stem Cell Transplantation; Co-Director, Immune Effector Cell Therapy; Co-Director, Adult CAR T-Cell Therapy Program

Biography

Dr. Seropian is a Professor of Medicine in the department of Internal Medicine, Section of Hematology, Yale University School of Medicine. He received his medical degree from George Washington University School of Medicine and completed residency and fellowship training at Yale-New Haven Hospital/Yale University School of Medicine in 1996.

Dr. Seropian serves as Interim Director of the Stem Cell Transplant Program, Co-Director, Immune Effector Cell Therapy, and Chairman, Car-T Cell Joint Steering Committee, Yale-New Haven Hospital. Dr. Seropian’s research interests include methods to improve the outcomes of transplantation through use of novel anti-cancer agents and new methods of treating graft versus host disease

Appointments

Other Departments & Organizations

Education & Training

Resident
Yale-New Haven Hospital (1994)
Intern
Yale-New Haven Hospital (1992)
MD
George Washington University (1991)
BS
Tufts University (1984)

Research

Overview

Medical Research Interests

Bone Marrow Transplantation; Clinical Trials, Phase III as Topic; Hematologic Diseases; Hematopoietic Stem Cells; Hodgkin Disease; Leukemia; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Plasma Cells

Public Health Interests

Clinical Trials; Cancer

Research at a Glance

Yale Co-Authors

Frequent collaborators of Stuart Seropian's published research.

Publications

2024

See All Publications

Clinical Trials

Current Trials

See All Current Clinical Trials

Academic Achievements & Community Involvement

  • activity

    Advisory Board

    Advisory BoardsMember
  • activity

    Bone Marrow Transplantation

    Journal ServiceReviewer
  • activity

    Transfusion

    Journal ServiceReviewer
  • activity

    Hodgkin’s Lymphoma Guidelines Panel, National Comprehensive Cancer Center Network

    Peer Review Groups and Grant Study SectionsCommittee Member
  • activity

    EMR User Group, Center for International Blood and Marrow Transplantation Research (CIBMTR)

    Public ServiceMember
See All Achievements

Clinical Care

Overview

Stuart Seropian, MD, is a medical oncologist who specializes in treating patients with blood cancers, including acute and chronic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. Dr. Seropian also sees patients with non-cancerous bone marrow disorders, including aplastic anemia. He is director of the adult Stem Cell Transplant program and co-director of the CAR T-cell Therapy Program for adults.

In medical school, Dr. Seropian enjoyed studying the biology of cancer and wanted to provide long-term patient care, which led to his pursuing medical oncology. “I have patients who see me as their primary care physician—as the doctor most responsible for their long-term care,” Dr. Seropian says. “Patients will say they’ve experienced a physician who had one foot out the door before all questions were answered. But the relationship with the patient is vital for cancer treatment.”

During his career, Dr. Seropian has witnessed treatment options for patients with blood cancers improve by leaps and bounds, from chemotherapy to the personalized CAR T-cell and stem cell transplantation therapies.

“The general view among the public is that cancer is terminal,” Dr. Seropian says. “People are always surprised to hear that cure rates [for certain cancers] range from 30 to 65 percent.”

He points out that a transplant physician is one of many providers of care in a large cast, which includes other physician subspecialists, nurse practitioners, nurses, coordinators, laboratory physicians and technicians. “Patients who come here are cared for by a family of people,” he says.

Dr. Seropian is an associate professor of medicine (hematology) at Yale School of Medicine.

Clinical Specialties

Hematologic Oncology; Leukemia & Lymphoma; Hematology

Fact Sheets

See All Fact Sheets On Yale Medicine

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number
Clinic Fax Number
Mailing Address

Yale Cancer Center

PO Box 208028, 333 Cedar Street, TMP 3

New Haven, CT 06520-8028

United States

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    See Patient Care Locations